Share
Journal Information
Issue
Vol. 44. Issue 3.Pages 125-206 (April 2020)
Editorial
Update of the Andalusian Association of Urology protocol for the management of metastatic castration-resistant prostate cancer
J.L. Álvarez-Ossorio, J.M. Cozar-Olmo, Á. Juárez-Soto, R. Medina-López, J. Moreno-Jiménez, M.J. Requena-Tapia
Actas Urol Esp. 2020;44:125-30
Review articles
The relationship between inguinal hernia and minimally-invasive surgery for prostate cancer: A systematic review of the literature
R. Bertolo, M.C. Mir Maresma, P. Bove, J. Rubio-Briones, M. Ramírez-Backhaus
Actas Urol Esp. 2020;44:131-8
Liquid biopsy and prostate cancer. Current evidence applied to clinical practice
I. Puche-Sanz, A. Rodríguez-Martínez, M.C. Garrido-Navas, I. Robles-Fernández, F. Vázquez-Alonso, M.J. Álvarez Cubero, J.A. Lorente-Acosta, M.J. Serrano-Fernández, J.M. Cózar-Olmo
Actas Urol Esp. 2020;44:139-47
Magnetic resonance as imaging diagnostic tool in prostate cancer: New evidences-The EAU section of uro-technology position
M. Álvarez-Maestro, J. Gómez Rivas, J. Quesada Olarte, D. Carrión Monsalve, C. Trelles Guzman, C. Ballesteros, L.M. Quintana, A. Aguilera Bazán, ... E. Barret
Actas Urol Esp. 2020;44:148-55
Original articles
Androgen deprivation therapy in patients with localized disease: Comparison with curative intent treatments and time to castration resistance. Results of the Spanish Prostate Cancer Registry
J. Garcia-Rodriguez, J.M. Fernandez-Gomez, J.M. Cozar, B. Miñana, F. Gomez-Veiga, A. Rodriguez-Antolin
Actas Urol Esp. 2020;44:156-63
Role of the neutrophil/lymphocyte ratio in patients with metastatic castration-resistant prostate cancer treated first-line with abiraterone
D. Nieblas-Toscano, A.J. Arenas-Bonilla, J.F. Flores-Martín, F. Gutiérrez-Tejero, C. Velarde-Muñoz, C.I. Ramos-Alaminos, M.C. Salas-Moreno, R. Galisteo-Moya, J. Moreno-Jiménez
Actas Urol Esp. 2020;44:164-71
Whole and hemi-gland cryoablation for primary localized prostate cancer: Short and medium-term oncological and functional outcomes
R. Boissier, F. Sanguedolce, A. Territo, D. Vanacore, C. Martinez, F. Regis, A. Gallioli, A. Mercade, ... A. Breda
Actas Urol Esp. 2020;44:172-8
Oncologic outcomes in 408 consecutive patient cohort treated with da Vinci robot-assisted radical prostatectomy
J. Moreno-Sierra, M.I. Galante-Romo, J.L. Senovilla-Perez, E. Redondo-González, I. Galindo-Herrero, J. Barrera-Ortega, R. Vives-Dilmes, J. Ariño-Irujo, ... C. Fernández-Perez
Actas Urol Esp. 2020;44:179-86
The impact of time from biopsy to radical prostatectomy on Gleason score undergrading and other related factors
A.J. Virseda Rodríguez, S. Marcos Asensio, M. Herrero Polo, T. Hernández Sanchez, A. Sanz Ruiz, F. García, F. Vesga, E. Gutiérrez, ... F. Gómez Veiga
Actas Urol Esp. 2020;44:187-95
Complications of transrectal prostate biopsy in our context. International multicenter study of 3350 patients
M. Perán Teruel, M.F. Lorenzo-Gómez, N. Veiga Canuto, B.Y. Padilla-Fernández, L.S. Valverde-Martínez, F. Migliorini, B. Jorge Pereira, H.M. Pires Coelho, J.M. Osca García
Actas Urol Esp. 2020;44:196-204
Letter to the editor
Regarding androgen deprivation therapy, we must use the correct Spanish translation for deprivation, privación; not the anglicism deprivación
J. Muñoz-Rodríguez, A. Domínguez
Actas Urol Esp. 2020;44:205-6
Publish in
Actas Urológicas Españolas
Actas Urológicas Españolas (English Edition) is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.
Free access articles
Actas Urol Esp. 2024;48:623-31
Actas Urol Esp. 2024;48:461-9
10.1016/j.acuroe.2024.11.002